Department of
The Department of Anesthesiology is proud to recognize five of its Advanced Practice Providers (APPs) who have been named finalists for the March of Dimes Heroes in Action 2026 awards.
Trish Wilkinson, MSN, ACNP-BC, has been appointed Director of Critical Care APPs. A 14-year division veteran, she will oversee nearly 100 APPs across academic, community, and tele-critical care settings.
WashU Medicine Department of Anesthesiology faculty members were recognized at the Academy of Educators Education Day in October 2026, recognizing their contributions to education and their commitment to developing the next generation of healthcare professionals.
As a pediatric anesthesiologist, Difficult Airway Service director and Residency Program Director, Dr. Nykiel-Basiley wears a lot of hats at WashU Medicine. But outside the hospital, she’s also a mom, wife and friend who makes time for family, the outdoors and a little friendly competition. Here’s a look at a day in her life, both in and out of the hospital.
This month’s newsletter explores how taking small steps toward the tasks we’ve been avoiding can ease stress, clear mental clutter and help us make the most of WashU’s wellness resources.
Ream Al-Hasani, PhD, associate professor of anesthesiology at WashU Medicine, has been elected president-elect of the International Society for Monitoring Molecules in Neuroscience (MMiN).
Support from the Dr. Seymour & Rose T. Brown Professorship helped Dr. Rob Gereau turn an early research idea into a promising path toward safer, more effective treatments for chronic pain.
WashU Medicine researchers have uncovered new insights into the pharmacology of ketamine that help explain both its rapid benefits and its risks.
Clinical trial supports adding mental health coaching, medication cleanup to routine pre-surgical care.
Jordan McCall, Ream Al-Hasani, and Jose Moron-Concepcion, faculty in the Department of Anesthesiology at WashU Medicine, have received a five-year, $3,414,110 grant from NIDA to investigate how fentanyl use disrupts the brain’s noradrenergic locus coeruleus system and drives relapse.